{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T14:57:19Z","timestamp":1787065039156,"version":"build-2736575974"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Italian Ministry of University and Research","award":["CTN01_00230_413096"],"award-info":[{"award-number":["CTN01_00230_413096"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology in Vitro"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.tiv.2016.12.014","type":"journal-article","created":{"date-parts":[[2017,1,5]],"date-time":"2017-01-05T07:46:36Z","timestamp":1483602396000},"page":"124-133","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["CYP4F2 repression and a modified alpha-tocopherol (vitamin E) metabolism are two independent consequences of ethanol toxicity in human hepatocytes"],"prefix":"10.1016","volume":"40","author":[{"given":"A.","family":"Russo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3849-757X","authenticated-orcid":false,"given":"D.","family":"Bartolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Torquato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Giusepponi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Barola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Galarini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Birringer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Lorkowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Galli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tiv.2016.12.014_bb0005","doi-asserted-by":"crossref","first-page":"355","DOI":"10.3109\/00365513.2013.786121","article-title":"Peroxisome proliferator activated receptor (PPAR)-gamma concentrations in childhood obesity","volume":"73","author":"Akyurek","year":"2013","journal-title":"Scand. J. Clin. Lab. Invest."},{"key":"10.1016\/j.tiv.2016.12.014_bb0010","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/FPC.0000000000000100","article-title":"PharmGKB summary: very important pharmacogene information for CYP4F2","volume":"25","author":"Alvarellos","year":"2015","journal-title":"Pharmacogenet. Genomics"},{"key":"10.1016\/j.tiv.2016.12.014_bb0015","doi-asserted-by":"crossref","first-page":"12182","DOI":"10.3748\/wjg.v20.i34.12182","article-title":"Management of nonalcoholic fatty liver disease: an evidence-based clinical practice review","volume":"20","author":"Arab","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.tiv.2016.12.014_bb0025","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1194\/jlr.M030734","article-title":"Disruption of P450-mediated vitamin E hydroxylase activities alters vitamin E status in tocopherol supplemented mice and reveals extra-hepatic vitamin E metabolism","volume":"53","author":"Bardowell","year":"2012","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.tiv.2016.12.014_bb0030","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.freeradbiomed.2016.04.130","article-title":"Analytical and molecular insights in the cytocrome P450 metabolism of vitamin E and lipotoxicity mechanisms of non-alcoholic fatty liver","volume":"96","author":"Bartolini","year":"2016","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.tiv.2016.12.014_bb0035","doi-asserted-by":"crossref","first-page":"S60","DOI":"10.1016\/j.freeradbiomed.2016.04.130","article-title":"Analytical and molecular insights in the cytochrome P450 metabolism of vitamin E and lipotoxicity mechanisms of non-alcoholic fatty liver","volume":"96","author":"Bartolini","year":"2016","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.tiv.2016.12.014_bb0040","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.freeradbiomed.2015.06.039","article-title":"Glutathione S-transferase pi expression regulates the Nrf2-dependent response to hormetic diselenides","volume":"88","author":"Bartolini","year":"2015","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.tiv.2016.12.014_bb0045","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1016\/j.freeradbiomed.2015.07.143","article-title":"Cytochrome P450 metabolism of vitamin E in models of non-alcoholic fatty liver disease and steatohepatitis","volume":"86","author":"Bartolini","year":"2015","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.tiv.2016.12.014_bb0050","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.freeradbiomed.2006.04.012","article-title":"Antiproliferative effects of tocopherols (vitamin E) on murine glioma C6 cells: homologue-specific control of PKC\/ERK and cyclin signaling","volume":"41","author":"Betti","year":"2006","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.tiv.2016.12.014_bb0055","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/S0891-5849(01)00574-3","article-title":"Tocopherols are metabolized in HepG2 cells by side chain omega-oxidation and consecutive beta-oxidation","volume":"31","author":"Birringer","year":"2001","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.tiv.2016.12.014_bb0060","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/j.freeradbiomed.2010.07.024","article-title":"Proapoptotic effects of long-chain vitamin E metabolites in HepG2 cells are mediated by oxidative stress","volume":"49","author":"Birringer","year":"2010","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.tiv.2016.12.014_bb0065","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1210\/endo.140.1.6457","article-title":"c-Jun N-terminal kinase phosphorylates peroxisome proliferator-activated receptor-gamma1 and negatively regulates its transcriptional activity","volume":"140","author":"Camp","year":"1999","journal-title":"Endocrinology"},{"key":"10.1016\/j.tiv.2016.12.014_bb0070","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.cld.2012.08.002","article-title":"Alcohol metabolism","volume":"16","author":"Cederbaum","year":"2012","journal-title":"Clin. Liver Dis."},{"key":"10.1016\/j.tiv.2016.12.014_bb0075","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1053\/j.gastro.2012.04.001","article-title":"The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology","volume":"142","author":"Chalasani","year":"2012","journal-title":"Gastroenterology"},{"issue":"532\u2013534","key":"10.1016\/j.tiv.2016.12.014_bb0080","first-page":"536","article-title":"A reagent for the single-step simultaneous isolation of RNA, DNA and proteins from cell and tissue samples","volume":"15","author":"Chomczynski","year":"1993","journal-title":"Biotechniques"},{"key":"10.1016\/j.tiv.2016.12.014_bb0085","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.freeradbiomed.2015.08.019","article-title":"Human serum determination and in vitro anti-inflammatory activity of the vitamin E metabolite alpha-(13\u2032-hydroxy)-6-hydroxychroman","volume":"89","author":"Ciffolilli","year":"2015","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.tiv.2016.12.014_bb0090","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.cbi.2015.02.016","article-title":"Chemoprotective effect of vitamin E in cyclophosphamide-induced hepatotoxicity in rats","volume":"232","author":"Cuce","year":"2015","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.tiv.2016.12.014_bb0095","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1194\/jlr.M047357","article-title":"Dietary omega-3 fatty acids modulate the eicosanoid profile in man primarily via the CYP-epoxygenase pathway","volume":"55","author":"Fischer","year":"2014","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.tiv.2016.12.014_bb0100","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1124\/pr.113.007781","article-title":"The pharmacology of the cytochrome P450 epoxygenase\/soluble epoxide hydrolase axis in the vasculature and cardiovascular disease","volume":"66","author":"Fleming","year":"2014","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.tiv.2016.12.014_bb0105","article-title":"Vitamin E: emerging aspects and new directions","author":"Galli","year":"2016","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.tiv.2016.12.014_bb0110","article-title":"Vitamin E: emerging aspects and new directions","author":"Galli","year":"2016","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.tiv.2016.12.014_bb0115","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.freeradbiomed.2016.09.017","article-title":"Vitamin E: emerging aspects and new directions","volume":"102","author":"Galli","year":"2017","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.tiv.2016.12.014_bb0120","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0083-6729(07)76009-0","article-title":"Vitamin E biotransformation in humans","volume":"76","author":"Galli","year":"2007","journal-title":"Vitam. Horm."},{"key":"10.1016\/j.tiv.2016.12.014_bb0130","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1258\/ebm.2009.009249","article-title":"Pathogenesis of alcoholic liver disease: the role of nuclear receptors","volume":"235","author":"Gyamfi","year":"2010","journal-title":"Exp. Biol. Med. (Maywood)"},{"key":"10.1016\/j.tiv.2016.12.014_bb0135","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1016\/j.bcp.2008.03.004","article-title":"Cytochrome P450 omega hydroxylase (CYP4) function in fatty acid metabolism and metabolic diseases","volume":"75","author":"Hardwick","year":"2008","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.tiv.2016.12.014_bb0140","doi-asserted-by":"crossref","first-page":"952734","DOI":"10.1155\/2009\/952734","article-title":"PPAR\/RXR regulation of fatty acid metabolism and fatty acid omega-hydroxylase (CYP4) isozymes: implications for prevention of lipotoxicity in fatty liver disease","volume":"2009","author":"Hardwick","year":"2009","journal-title":"PPAR Res."},{"key":"10.1016\/j.tiv.2016.12.014_bb0145","doi-asserted-by":"crossref","DOI":"10.1177\/1535370216636719","article-title":"Effect of silibinin and vitamin E on the ASK1-p38 MAPK pathway in d-galactosamine\/lipopolysaccharide induced hepatotoxicity","author":"Hashem","year":"2016","journal-title":"Exp. Biol. Med. (Maywood)"},{"key":"10.1016\/j.tiv.2016.12.014_bb0150","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/1753-0407.12358","article-title":"Soluble epoxide hydrolase: a potential target for metabolic diseases","volume":"8","author":"He","year":"2016","journal-title":"J. Diabetes"},{"key":"10.1016\/j.tiv.2016.12.014_bb0155","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0887-2333(02)00122-4","article-title":"Discriminating two classes of toxicants through expression analysis of HepG2 cells with DNA arrays","volume":"17","author":"Hong","year":"2003","journal-title":"Toxicol. in Vitro"},{"key":"10.1016\/j.tiv.2016.12.014_bb0160","doi-asserted-by":"crossref","first-page":"5225","DOI":"10.1074\/jbc.M608176200","article-title":"Regulation of human cytochrome P450 4F2 expression by sterol regulatory element-binding protein and lovastatin","volume":"282","author":"Hsu","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tiv.2016.12.014_bb0175","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.tox.2005.03.007","article-title":"Diazinon-induced hepatotoxicity and protective effect of vitamin E on some biochemical indices and ultrastructural changes","volume":"211","author":"Kalender","year":"2005","journal-title":"Toxicology"},{"key":"10.1016\/j.tiv.2016.12.014_bb0180","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.pharmthera.2006.03.008","article-title":"Cytochrome P450 4F subfamily: at the crossroads of eicosanoid and drug metabolism","volume":"112","author":"Kalsotra","year":"2006","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.tiv.2016.12.014_bb0190","doi-asserted-by":"crossref","first-page":"12953","DOI":"10.1074\/jbc.270.22.12953","article-title":"An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma)","volume":"270","author":"Lehmann","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tiv.2016.12.014_bb0195","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1124\/dmd.110.036848","article-title":"CYP4F3B expression is associated with differentiation of HepaRG human hepatocytes and unaffected by fatty acid overload","volume":"39","author":"Madec","year":"2011","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.tiv.2016.12.014_bb0200","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.tiv.2016.12.014_bb0205","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0165-6147(00)01559-5","article-title":"PPAR-gamma agonists: therapeutic role in diabetes, inflammation and cancer","volume":"21","author":"Murphy","year":"2000","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.tiv.2016.12.014_bb0210","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1194\/jlr.M500143-JLR200","article-title":"Intracellular trafficking of vitamin E in hepatocytes: the role of tocopherol transfer protein","volume":"46","author":"Qian","year":"2005","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.tiv.2016.12.014_bb0215","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/nprot.2008.73","article-title":"Analyzing real-time PCR data by the comparative C(T) method","volume":"3","author":"Schmittgen","year":"2008","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.tiv.2016.12.014_bb0220","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S0016-5085(98)70644-4","article-title":"Vitamin E reduces oxidant injury to mitochondria and the hepatotoxicity of taurochenodeoxycholic acid in the rat","volume":"114","author":"Sokol","year":"1998","journal-title":"Gastroenterology"},{"key":"10.1016\/j.tiv.2016.12.014_bb0225","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1016\/j.freeradbiomed.2016.04.159","article-title":"Alpha-13\u2032-OH is the main product of alpha-tocopherol metabolism and influences CYP4F2 and PPARgamma gene expression in HepG2 human hepatocarcinoma cells","volume":"96","author":"Torquato","year":"2016","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.tiv.2016.12.014_bb0230","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.jpba.2016.01.056","article-title":"Analytical strategies to assess the functional metabolome of vitamin E","volume":"124","author":"Torquato","year":"2016","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.tiv.2016.12.014_bb0235","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.freeradbiomed.2007.03.024","article-title":"Vitamin E, antioxidant and nothing more","volume":"43","author":"Traber","year":"2007","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.tiv.2016.12.014_bb0240","first-page":"5","article-title":"The bicinchoninic acid (BCA) assay for protein quantitation","volume":"32","author":"Walker","year":"1994","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.tiv.2016.12.014_bb0245","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.freeradbiomed.2013.11.009","article-title":"Long-chain metabolites of alpha-tocopherol occur in human serum and inhibit macrophage foam cell formation in vitro","volume":"68","author":"Wallert","year":"2014","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.tiv.2016.12.014_bb0250","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.redox.2014.02.002","article-title":"Regulatory metabolites of vitamin E and their putative relevance for atherogenesis","volume":"2","author":"Wallert","year":"2014","journal-title":"Redox Biol."},{"key":"10.1016\/j.tiv.2016.12.014_bb0255","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1002\/mnfr.201400737","article-title":"Alpha-tocopherol long-chain metabolite alpha-13\u2032-COOH affects the inflammatory response of lipopolysaccharide-activated murine RAW264.7 macrophages","volume":"59","author":"Wallert","year":"2015","journal-title":"Mol. Nutr. Food Res."},{"key":"10.1016\/j.tiv.2016.12.014_bb0260","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1007\/s00535-015-1050-7","article-title":"Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease\/nonalcoholic steatohepatitis","volume":"50","author":"Watanabe","year":"2015","journal-title":"J. Gastroenterol."},{"key":"10.1016\/j.tiv.2016.12.014_bb0265","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/978-3-319-16009-2_6","article-title":"Cytochrome p450 enzymes in the bioactivation of polyunsaturated fatty acids and their role in cardiovascular disease","volume":"851","author":"Westphal","year":"2015","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.tiv.2016.12.014_bb0270","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.jprot.2016.01.016","article-title":"In-depth quantitative analysis and comparison of the human hepatocyte and hepatoma cell line HepG2 proteomes","volume":"136","author":"Wisniewski","year":"2016","journal-title":"J. Proteome"},{"key":"10.1016\/j.tiv.2016.12.014_bb0275","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.pharmthera.2012.12.007","article-title":"Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation","volume":"138","author":"Zanger","year":"2013","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.tiv.2016.12.014_bb0280","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1006\/abbi.2000.1836","article-title":"Promoter activity and regulation of the CYP4F2 leukotriene B(4) omega-hydroxylase gene by peroxisomal proliferators and retinoic acid in HepG2 cells","volume":"378","author":"Zhang","year":"2000","journal-title":"Arch. Biochem. Biophys."}],"container-title":["Toxicology in Vitro"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887233316302703?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887233316302703?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,17]],"date-time":"2019-09-17T01:20:49Z","timestamp":1568683249000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0887233316302703"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":51,"alternative-id":["S0887233316302703"],"URL":"https:\/\/doi.org\/10.1016\/j.tiv.2016.12.014","relation":{},"ISSN":["0887-2333"],"issn-type":[{"value":"0887-2333","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CYP4F2 repression and a modified alpha-tocopherol (vitamin E) metabolism are two independent consequences of ethanol toxicity in human hepatocytes","name":"articletitle","label":"Article Title"},{"value":"Toxicology in Vitro","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tiv.2016.12.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}